newsfilter
← Latest News
PR Newswire·

Senda Biosciences Announces Close of $123 Million Series C Financing

CAMBRIDGE, Mass., Aug. 16, 2022 /PRNewswire/ -- Senda Biosciences, Inc., a company that is harnessing nature to program targeted, potent, and tunable medicines, today announced the completion of a $123 million Series C financing, bringing its total fu